Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns
Jane Robertson(Cancer Research UK), Rajesh Chopra(Vardhman Mahavir Medical College & Safdarjung Hospital), M Dougal(The Christie Hospital), David C. Linch(University of Oxford), Nydia G. Testa(Wellcome Centre for Cell-Matrix Research), Robert Wynn(Royal Manchester Children's Hospital), Rosemary E. Gale(London Cancer)
Cited by 96
Related Papers
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study
|Blood|2006|843
Immunomodulatory agents lenalidomide and pomalidomide co‐stimulate <scp>T</scp> cells by inducing degradation of <scp>T</scp> cell repressors <scp>I</scp> karos and <scp>A</scp> iolos via modulation of the <scp>E</scp> 3 ubiquitin ligase complex <scp>CRL</scp> 4 <scp> <sup>CRBN</sup> </scp>
|British Journal of Haematology|2013|619
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation
|Blood|2000|502
Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial
|The Lancet|2012|376
Phase I Clinical Study of AZD2171, an Oral Vascular Endothelial Growth Factor Signaling Inhibitor, in Patients With Advanced Solid Tumors
|Journal of Clinical Oncology|2007|303